Positron (New York) Overview

  • Year Founded
  • 1983

Year Founded

  • Status
  • Public

  • Employees
  • 10

Employees

  • Stock Symbol
  • POSC

Stock Symbol

  • Investments
  • 5

  • Share Price
  • $1.65
  • (As of Tuesday Closing)

Positron (New York) General Information

Description

Positron Corp is a medical technology company engaged in the co-development, manufacture, and sale of PET and PET-CT imaging systems, delivering high-performance, cost-effective molecular imaging solutions that empower healthcare providers to improve the diagnosis and treatment of cardiovascular disease and other critical conditions. By combining proprietary PET and PET-CT systems with comprehensive clinical and technical support, flexible financing, & a focus on operational efficiency, Positron makes advance diagnostic imaging more accessible & sustainable for hospitals, outpatient centers, & physician practices. The company focused on advancing positron emission tomography imaging through the development, manufacture, & commercialization of PET & PET-computed tomography imaging systems.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 1777 Maryland Avenue
  • Niagara Falls, NY 14305
  • United States
+1 (317)
Primary Industry
Diagnostic Equipment
Stock Exchange
OTCM
Corporate Office
  • 1777 Maryland Avenue
  • Niagara Falls, NY 14305
  • United States
+1 (317)

Positron (New York) Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Positron (New York) Stock Performance

As of 17-Nov-2026, Positron (New York)’s stock price is $1.65. Its current market cap is $54.2M with 32.8M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.65 $1.65 $1.27 - $2.74 $54.2M 32.8M 16.8K -$0.32

Positron (New York) Financials Summary

As of 30-Sep-2026, Positron (New York) has a trailing 12-month revenue of $436K.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2014 31-Dec-2014
EV 59,982 52,445 26,189 8,222
Revenue 436 461 588 1,466
EBITDA (9,908) (10,459) (2,167) (609)
Net Income (10,072) (10,603) (2,379) (2,584)
Total Assets 3,657 4,000 1,801 1,869
Total Debt 3,087 1,947 2,057 470
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Positron (New York) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Positron (New York)‘s full profile, request access.

Request a free trial

Positron (New York) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Positron Corp is a medical technology company engaged in the co-development, manufacture, and sale of PET and PET-CT ima
Diagnostic Equipment
Niagara Falls, NY
10 As of 2026

Chicago, IL
 

Irvine, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Positron (New York) Competitors (15)

One of Positron (New York)’s 15 competitors is GE HealthCare Technologies, a Corporation company based in Chicago, IL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GE HealthCare Technologies Corporation Chicago, IL
Agendia Venture Capital-Backed Irvine, CA
DESTINA Formerly VC-backed Granada, Spain
Arthrex Private Equity-Backed Naples, FL
Asuragen Formerly VC-backed Austin, TX
You’re viewing 5 of 15 competitors. Get the full list »

Positron (New York) Patents

Positron (New York) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20120305789-A1 Method and device for quality control of radiopharmaceuticals Inactive 01-Jun-2011
US-D648360-S1 Actuator bridge Inactive 28-Oct-2010

Positron (New York) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Positron (New York) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Positron (New York)‘s full profile, request access.

Request a free trial

Positron (New York) Investments & Acquisitions (5)

Positron (New York)’s most recent deal was a Merger/Acquisition with Manhattan Isotope Technology for . The deal was made on 17-Jan-2012.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Manhattan Isotope Technology 17-Jan-2012 Merger/Acquisition Biotechnology
Dose Shield 11-Jun-2008 Merger/Acquisition Other Devices and Supplies
Imaging Pet Technologies 26-Jan-2007 Merger/Acquisition Monitoring Equipment
IS2 Medical Systems 06-Jun-2006 Merger/Acquisition Diagnostic Equipment
Imaging Pet Technologies 28-Dec-2005 Joint Venture Monitoring Equipment
To view Positron (New York)’s complete investments and acquisitions history, request access »

Positron (New York) ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Positron (New York)’s complete esg history, request access »

Positron (New York) FAQs

  • When was Positron (New York) founded?

    Positron (New York) was founded in 1983.

  • Where is Positron (New York) headquartered?

    Positron (New York) is headquartered in Niagara Falls, NY.

  • What is the size of Positron (New York)?

    Positron (New York) has 10 total employees.

  • What industry is Positron (New York) in?

    Positron (New York)’s primary industry is Diagnostic Equipment.

  • Is Positron (New York) a private or public company?

    Positron (New York) is a Public company.

  • What is Positron (New York)’s stock symbol?

    The ticker symbol for Positron (New York) is POSC.

  • What is the current stock price of Positron (New York)?

    As of 17-Nov-2026 the stock price of Positron (New York) is $1.65.

  • What is the current market cap of Positron (New York)?

    The current market capitalization of Positron (New York) is $54.2M.

  • What is Positron (New York)’s current revenue?

    The trailing twelve month revenue for Positron (New York) is $436K.

  • Who are Positron (New York)’s competitors?

    GE HealthCare Technologies, Agendia, DESTINA, Arthrex, and Asuragen are some of the 15 competitors of Positron (New York).

  • What is Positron (New York)’s annual earnings per share (EPS)?

    Positron (New York)’s EPS for 12 months was -$0.32.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process